ENVX Quote, Financials, Valuation and Earnings

Ideal Power has a net margin of -461.16% compared to Enovix's net margin of -22519.57%. Enovix's return on equity of -93.82% beat Ideal Power's return on equity of -55.02%.

Enovix has a consensus price target of $17.60, signalling upside risk potential of 222.92%. On the other hand Ideal Power has an analysts' consensus of $4.20 which suggests that it could fall by -16.17%. Given that Enovix has higher upside potential than Ideal Power, analysts believe Enovix is more attractive than Ideal Power.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ideal Power has a beta of 1.194, suggesting its more volatile than the S&P 500 by 19.368%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ideal Power offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Ideal Power pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $5.1M, which are larger than Ideal Power quarterly revenues of $12K. Enovix's net income of -$23.5M is lower than Ideal Power's net income of -$2.7M. Notably, Enovix's price-to-earnings ratio is -- while Ideal Power's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 61.38x versus 480.97x for Ideal Power. Usually stocks with elevated PS ratios are considered overvalued.

Plug Power has a net margin of -461.16% compared to Enovix's net margin of -147.12%. Enovix's return on equity of -93.82% beat Plug Power's return on equity of -79.04%.

Enovix has a consensus price target of $17.60, signalling upside risk potential of 222.92%. On the other hand Plug Power has an analysts' consensus of $1.87 which suggests that it could grow by 140.22%. Given that Enovix has higher upside potential than Plug Power, analysts believe Enovix is more attractive than Plug Power.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Plug Power has a beta of 2.187, suggesting its more volatile than the S&P 500 by 118.686%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plug Power offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Plug Power pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $5.1M, which are smaller than Plug Power quarterly revenues of $133.7M. Enovix's net income of -$23.5M is higher than Plug Power's net income of -$196.7M. Notably, Enovix's price-to-earnings ratio is -- while Plug Power's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 61.38x versus 1.05x for Plug Power. Usually stocks with elevated PS ratios are considered overvalued.

Tecogen has a net margin of -461.16% compared to Enovix's net margin of -9.07%. Enovix's return on equity of -93.82% beat Tecogen's return on equity of -38.16%.

Enovix has a consensus price target of $17.60, signalling upside risk potential of 222.92%. On the other hand Tecogen has an analysts' consensus of -- which suggests that it could fall by -2.17%. Given that Enovix has higher upside potential than Tecogen, analysts believe Enovix is more attractive than Tecogen.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tecogen has a beta of 0.455, suggesting its less volatile than the S&P 500 by 54.531%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tecogen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Tecogen pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $5.1M, which are smaller than Tecogen quarterly revenues of $7.3M. Enovix's net income of -$23.5M is lower than Tecogen's net income of -$659.9K. Notably, Enovix's price-to-earnings ratio is -- while Tecogen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 61.38x versus 4.83x for Tecogen. Usually stocks with elevated PS ratios are considered overvalued.

Ultralife has a net margin of -461.16% compared to Enovix's net margin of 3.68%. Enovix's return on equity of -93.82% beat Ultralife's return on equity of 3.96%.

Enovix has a consensus price target of $17.60, signalling upside risk potential of 222.92%. On the other hand Ultralife has an analysts' consensus of $14.00 which suggests that it could grow by 156.41%. Given that Enovix has higher upside potential than Ultralife, analysts believe Enovix is more attractive than Ultralife.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ultralife has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.912%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ultralife offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Ultralife pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $5.1M, which are smaller than Ultralife quarterly revenues of $50.7M. Enovix's net income of -$23.5M is lower than Ultralife's net income of $1.9M. Notably, Enovix's price-to-earnings ratio is -- while Ultralife's PE ratio is 17.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 61.38x versus 0.53x for Ultralife. Usually stocks with elevated PS ratios are considered overvalued.